Cardiologists; nurse practitioners (NPs); physician assistants (PAs); and other clinicians engaged in the care of patients with hypercholesterolemia
Hypercholesterolemia; dyslipidemia, ASCVD
This 2-part educational series is designed to first enhance learner knowledge of new and emerging treatment options in the hypercholesterolemia space and then provide practical approaches for integrating knowledge learned in the clinic setting through a case-based presentation. This first activity in the series will address new data and includes discussion of new mechanisms of action and their impact on hypercholesterolemia.
Although statins are the mainstay of hypercholesterolemia management, many patients do not achieve optimal LDL-C levels due to problems with adherence or lack of familiarity with available agents. Moreover, 7%–29% of patients may not tolerate statin‐based treatment, which leads to medication non-adherence, increased incidence of atherosclerotic cardiovascular disease (ASCVD) events, and higher healthcare costs. With increasing numbers of non-statin lipid lowering therapies available and in development, it is critical for clinicians to be aware of the mechanisms of action and clinical trial data for these agents, as well as how best these can be utilized to manage hypercholesterolemia.
Association of Black Cardiologists Accreditation Statement
Association of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Association of Black Cardiologists Credit Designation Statement
Association of Black Cardiologists, Inc. designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AANP Accreditation Statement
National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.5 contact hours (which includes 0.5 hours of pharmacology).
How to claim credit
Policy on Faculty and Provider Disclosure
Accredited education provided by the National Association for Continuing Education (NACE) and ABC must demonstrate balance, independence, objectivity, and scientific rigor. All individuals in a position to influence content of NACE and ABC accredited education are required to disclose all financial relationships with ineligible companies within the previous 24-month period, regardless of relevance to the education. All relevant financial relationships and potential conflicts of interest have been mitigated.
Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Faculty and Planning Committee Disclosures
James Underberg has disclosed the following financial relationships:
- Consultant: Amgen
- Advisory Board Member: Amgen, Alexion, Akcea, Amarin, Esperion, Novartis
- Speakers Bureau: Aegerion, Amarin, Amgen, Amryt, Esperion
- Speaking and Teaching: Medintelligence
- Contracted Research: Amryt
Karol Watson has disclosed the following financial relationships:
- Consultant: Amarin, Amgen, Boehringer Ingelheim, Esperion, Lilly
- Advisory Board Member: Amarin, Amgen, Boehringer Ingelheim, Esperion, Lilly
- Speakers Bureau: Boehringer Ingelheim, Lilly
- Speaker: Amarin, Amgen, Boehringer Ingelheim, Esperion, Lilly
Gregg Sherman, MD, Activity Planning Committee, has no relevant conflicts of interest.
Michelle Frisch, MPH, Activity Planning Committee, has no relevant conflicts of interest.
Daniela Hiedra, Activity Planning Committee, has no relevant conflicts of interest.
Joshua Kilbridge, Medical Writer, has no relevant conflicts of interest.
Disclosure of Commercial Support
This educational activity is supported by an educational grant from Novartis Pharmaceuticals Corporation
Disclosure of Unlabeled/Investigational Uses of Products
The content of the presentations may include discussion of unapproved or investigational uses of product or devices.
Course format/medium: Internet CME Activity
Estimated time to complete the activity: 30 minutes
COURSE VIEWING REQUIREMENTS
|Supported Browsers: |
Google Chrome 60 or higher
Mozilla Firefox 60 or higher
Apple Safari 11.0 or higher
For video, install the latest version of Quicktime.
|Supported Phones & Tablets: |
iOS 9.3 and higher
Android 7.0 (Nougat or higher)
Microsoft Windows 8
|Additional Recommendations and Requirements|
|Display Resolution & Color Depth||Resolution |
- 960 X 768 minimum
- 1024 X 768 recommended min.
- 8 bits (256 colors) minimum
- 16 bits (High colors) minimum
|Audio||- Microphone |
- Speakers or headphones
- Audio recording support
|Word Processing||Software that can open, modify, and save documents in Rich Text Format (RTF). Microsoft Word and PowerPoint are recommended.|